Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01232985 | Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults | PHASE2 | COMPLETED | 17 | — | — | Oct 1, 2010 | Dec 1, 2010 | May 30, 2012 | 1 | United States |
Investigator Global Assessment of Atopic Dermatitis Severity
| Arm | Type | Description |
|---|---|---|
| RD047-26 | EXPERIMENTAL | Study Device |
| Name | Type | Description |
|---|---|---|
| RD047-26 | DEVICE | RD047-26 emollient gel |
Inclusion Criteria: * Written informed consent * Female or male, 18 to 65 years of age and in good general health * Clinical diagnosis of stable mild to moderate atopic dermatitis * Willing and able to follow study instructions and likely to complete all study requirements Exclusion Criteria: * S...